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Organic & Biomolecular Chemistry www.rsc.org/obc An O-protection strategy using tetrahydrofuranyl or tetrahydropyranyl has enabled the addition of a hydroxamate-containing unnatural amino acid to a suppressor tRNA, allowing for subsequent site-specific incorporation of the amino acid into the transcription factor, TFIIIA.
Introduction
Strategies for the preparation of tRNA acylated with unnatural amino acids have expanded the repertoire of chemical moieties that can be precisely placed within the structure of a protein. 1 A description of the most commonly used in vitro procedure to prepare tRNA aminoacylated with an unnatural amino acid is presented in Scheme 1A. [2] [3] [4] The activated cyanomethyl ester of an N α -protected amino acid is reacted with the hybrid dinucleotide, pdCpA, which is then joined enzymatically to a truncated tRNA lacking the two terminal 3' nucleotides. The advent of these techniques, however, has necessitated the development of new protecting groups that can be removed from the amino acid under conditions that will not induce hydrolysis of the labile aminoacyl linkage nor harm the nucleic acid. Unfortunately, the number of reagents that meet these requirements is limited, due mostly to complications that arise during chemical deprotection. Protection of nucleophilic side chains is required during the aminoacylation reaction to prevent formation of side products. 5 Nucleophilic groups on the side-chain of the amino acid can also compete effectively with the 2' and 3' hydroxyl groups of the adenosine nucleotide for reaction at the α-carbonyl carbon of the cyanomethyl ester. 5 To avoid significant deacylation of the tRNA, side chain protecting groups must be removed using mild conditions.
For convenience, deprotection of both the N α and the amino acid side chains is generally done simultaneously by utilizing protecting groups with related scissile susceptibility. For example, photolytic side chain protecting groups include the NVOC (6-nitroveratryloxycarbonyl) group for amines, 6-nitroveratryl ethers for hydroxyls and 6-nitroveratryl esters for side chain acids. 5, 6 This deprotection problem for side chains has also been circumvented using protecting groups that can be removed enzymatically (pyroglutamyl group) or chemically (4-penteneoyl group). 7, 8 We report here the successful use of two new groups for O-protection of a novel hydroxamate containing amino acid that can be used to site-specifically place a metal binding moiety into proteins. Both tetrahydrofuranyl and tetrahydropyranyl groups were used to protect the N ε hydroxyl of the hydroxamate, N ε -acetyl-N ε -hydroxy-L-lysine 1 (Scheme 1B). Both protecting groups can be efficiently removed from the aminoacylated amino acid in weakly acidic solution. The resulting aminoacyled tRNA exhibited good biosynthetic activity in an in vitro transcription/translation reaction, suppressing an amber stop codon in the coding sequence of transcription factor IIIA (TFIIIA) with 40% efficiency. The tetrahydrofuranyl and tetrahydropyranyl groups should find general utility for the protection of a variety of nucleophilic moieties in the side-chains of both native and unnatural amino acids. Since these groups are removed chemically, they provide a valuable orthogonal alternative in those cases,
i.e., light sensitive amino acids, when photodeprotection is not possible.
The hydroxamate containing amino acid described here is smaller and more hydrophilic than other metal-chelating unnatural amino acids that have been reported. [9] [10] [11] [12] Thus, we expect that incorporation of N ε -acetyl-N ε -hydroxy-L-lysine should have fewer adverse effects on the proper folding of proteins either in vitro or in vivo. Moreover, there should be fewer steric restrictions on the placement of this amino acid within a given protein, due to its compact size.
Results and discussion
Aminoacyl bond formation is a critical step in the pathway for the preparation of tRNA charged with an unnatural amino acid (Scheme 1). The cyanomethyl ester of an amino acid reacts quite specifically with the either the 2' or 3'-hydroxyl position on the hybrid dinucleotide, 5'-phospho-2'-deoxycytidylyl(3',5')adenosine (pdCpA), requiring no protection of the N4 position of the cytidine. 4, 5, 13 However, a nucleophilic functionality such as a hydroxyl, carboxyl, amide, or sulfhydryl group in the side-chain of the amino acid will readily react with the active ester, thereby preventing any significant acylation of the dinucleotide. Although there are several protecting groups that may be used to mask such functionalities, the subsequent removal of these groups from the amino acid, when present on the charged tRNA, poses special problems. The aminoacyl bond is especially susceptible to hydrolysis even at neutral pH.
Protecting groups such as carbobenzoxy (Cbz), nitrosulfenyl (NPS), and biphenylisopropyloxycarbonyl (Bpoc) are removed under conditions that leave the aminoacyl linkage intact; however, yields of deprotected acylated tRNA can be low and side-reactions with the RNA are possible in some cases. 14, 15 NVOC derivatives, which are removed by irradiation, have therefore been the most widely used protecting groups for N α and other nucleophilic positions in activated amino acids.
The side-chain hydroxamate group in the amino acid N ε -acetyl-N ε -hydroxy-L-lysine prevents aminoacylation of suppressor tRNA by the method outlined in Scheme 1. We have tested various protecting groups for this position in order to identify those that are compatible with the reaction of activated amino acid with pdCpA and subsequent deprotection of aminoacylated tRNA. Since the N α position is normally protected with the photoactivatable NVOC group, we tested the use of a second nitroveratryl group to protect the side-chain hydroxyl with the expectation that both protecting groups could be removed simultaneously.
The reaction of N α -(6-nitroveratryl)-N ε -acetyl-N ε -hydroxy-L-lysine with 6-nitroveratryl-O-tosyl alcohol proceeded poorly with appreciable hydrolysis of the NVOC group from the N α position.
Consequently, a synthetic scheme was devised in which protection of the side-chain hydroxyl precedes protection of the N α position (Scheme 2). Suitably protected hydroxamate precursors were prepared either through the formation of a nitrone or through epoxidation of a Schiff base according to published syntheses. 16 Following removal of the O-acyl group by amidolysis, the hydroxamate 2 was reacted with 6-nitroveratryl-O-tosyl alcohol. The Boc and t-butyl protecting groups were removed by treatment with trifluroacetic acid and the resulting O-protected hydroxamate 3 purified by reverse phase HPLC.
Photolytic removal of the O-nitroveratryl protecting group was studied using 3. The rate of photolysis was measured using analytical reverse phase HPLC to quantitate the amount of 3 remaining after irradiation. The conditions for photodeprotection were identical to those used to remove NVOC from the N α position. After 30 min of irradiation, more than 80% of the protected hydroxamate remained; moreover reverse phase TLC and FAB mass spectrometry experiments showed that the major deprotection product was N ε -acetyl-L-lysine and not the with the notion that the hydroxmate active ester is a better leaving group than the cyanomethylester. 5 We tested protection of 1 with a silyl protecting group, tert-butyldimethylsilyl (TBDMS), with the expectation that increased steric bulk would reduce reactivity at the N ε oxygen (Scheme 3). Similar protection of aryl hydroxyls has been reported previously. 21 Aminoacylation reactions with the hydroxamate protected with TBDMS, 6, yielded a mixture of N and O silylated dinucleotide, a complication similar to that encountered with the NVOC-protected amino acid 5.
The requirement for a more robust linkage that could be efficiently removed after aminoacylation under mild conditions led us to tetrahydrofuranyl (THF) and tetrahydropyranyl (THP) protecting groups. 22, 23 The full synthesis is described. The cyanomethyl ester of the unprotected hydroxamate 5 was prepared in two steps after NVOC protection of the amine Dilute trifluoroacetic acid, used to cleave the Bpoc protecting group from the N α position of aminoacylated pdCpA 24 , did not remove the THP group and prolonged incubation led to significant deacylation. However, incubation in a 3:1:1 acetic acid:water:DMF mixture proved quite effective for the removal of both THF and THP protecting groups with half-lives of 1.8 and 2.9 h respectively. Thus, the aminoacylation reaction could be followed by incubation in weak acid to deprotect only the hydroxamate side chain. Cyanomethyl ester mediated aminoacylation of the pdCpA by the THF protected hydroxamate 7b was followed by the addition of mild acid until the side chain was deprotected, with the 2'3'-monoacylated product 9 subsequently purified by HPLC (Figure 1 ). This aminoacylated hybrid dinucleotide 9 was conjugated to truncated tRNA and, just before use, subjected to photodeprotection.
The biological activity of the charged suppressor tRNA was tested using an in vitro protein synthesis extract (E. coli S30) programed with a plasmid encoding the transcription factor TFIIIA ( Figure 2 ). The coding sequence of the open reading frame contains an amber stop codon (TAG) at amino acid position 199 that normally encodes an arginine residue. Full-length TFIIIA is 344 amino acids. 25 The protein products of the translation reaction were analyzed by western blot using an antibody against TFIIIA. The reaction containing suppressor tRNA acylated with N ε -acetyl-N ε -hydroxy-L-lysine without photodeprotection produced no full-length protein (lane 4); whereas, deprotection of N α led to a suppression efficiency of 40% as measured by densitometry (lane 5). This robust activity demonstrates that deprotection of the amino acid in mild acid has no adverse effects on the biological activity of the aminoacylated dinucleotide Metals play a variety of roles in the structure and function of proteins. 26 The widespread occurrence of assorted zinc-binding motifs is just one example of the means by which metals enable and stabilize the folding and higher order structure of proteins. 27 Redox active metals such as iron and copper mediate diverse activities ranging from electron and oxygen transport to ribonucleotide reduction and deamination. [28] [29] [30] [31] Similarly, magnesium participates directly in the chemistry of several enzyme-catalyzed reactions, including the polynucleotide polymerases and nucleases. 32 It is well appreciated that the ability to engineer metal binding sites into proteins holds the potential to expand their function, creating, for example, novel imaging reagents, spectroscopic probes, and catalysts. [33] [34] [35] The specific positioning of metals in native proteins is accomplished by either of two means: through the precise configuration of amino acid side chains that form a coordination sphere or through the utilization of a prosthetic group. De novo design of new metal binding sites into proteins using either of these strategies has inherent difficulties that have been discussed at length. [33] [34] [35] [36] The first instance requires that the three-dimensional arrangement of amino acids used to create the binding site does not perturb the native structure of the protein.
The second instance faces the same challenge, if a binding site for the prosthetic group is desired.
Alternatively, direct linkage of a prosthetic group to an amino acid side chain is restricted to compatible sites on the surface of the protein. Given these appreciable technical challenges, there has been increasing effort to use unnatural amino acids to create novel metalloproteins either by solid-state synthesis of a polypeptide or by the genetically based strategy employed
here. There is a small number of cases where a metal-binding amino acid has been incorporated site-specifically using the latter method. [10] [11] [12] In these cases, the chelating moieties have been generally large and often hydrophobic, meaning there is the potential to either disrupt or, at least, perturb proper folding of the protein. Additionally, the hydrophobic nature of these moieties can potentially lead to protein aggregation at high concentrations as well as diminish the solubility of the acylated tRNA used to incorporate the amino acid during ribosome-based synthesis. The hydroxamate-containing amino acid described here obviates these complications and, thus,
represents an important addition to the family of metal-binding unnatural amino acids.
Conclusions
Naturally occurring hydroxamates are compact ligands that possess high single-ligand affinity for several metal cations, including Fe(III), Zn(II), and Cu(II). 37 Their chemical properties are especially well suited for protein engineering since they are polar, yet uncharged at physiological pH, suggesting that they will have little tendency to perturb native protein structure through either hydrophobic or electrostatic interactions. We have demonstrated that hydroxamates can be protected with groups (tetrahydrofuranyl and tetrahydropyranyl) whose efficient removal is compatible with the mild deprotection conditions imposed by the acylated dinucleotide. This opens the way for site-specific incorporation of this family of chelators into proteins of interest.
Experimental section

General procedures and methods
All organic reactions were conducted under nitrogen using baked glassware. 
hydroxy-O-(NVOC)-L-lysine cyanomethyl ester (4). N-6-
acetyl-N-6-hydroxy-L-lysine 1 (0.25g, 1.2 mmol) was dissolved in 2 mL of 1:1 (w/w) phenol: N α -NVOC-N ε ε ε ε -acetyl-N ε ε ε ε -hydroxy-L-lysine-pdCpA (9). The unpurified aminoacylation coupling reactions 100 µL with tetrahydrofuranyl or tetrahydropyranyl protection (8a or 8b) were dissolved in 300 µL of glacial acetic acid and 100 µL of water.
Reaction at 37°C was monitored by analytical HPLC in a manner identical to that for the synthesis of compound 8a/8b. The deprotected 2' and 3' O-acyl isomers eluted at 21 min.
Hydrolysis of the tetrahydrofuranyl and tetrahydropyranyl forms was observed to be quantitative with a t 1/2 of 1.8 h and 2.9 h, respectively. Preparative HPLC using the methods used to purify compound 8a/8b were used to acquire the deprotected form 9 which eluted at 15 min. Mass spectrum (MALDI) m/z 1067, expected for C 37 H 49 N 11 O 22 P 2 1061.
In vitro synthesis of tRNA Phe (CUA)-CA and enzymatic ligation
Plasmid pYΦ2 (gift from Dr. P.G. Schultz, Scripps Institute, CA) was used to prepare suppressor tRNA by runoff transcription. 4 Ligation of the aminoacylated dinucleotide was performed as follows. tRNA (7.0 µg, 0. 
Photodeprotection of tRNA (CUA) aminoacylated with NVOC-protected amino acids
Photoprotection was carried out using a 400 W Hg (Xe) lamp (Oriel) with a 6 cm focal length Pyrex lens. Aminoacylated tRNA was resuspended in 1.0 mM KOAc pH 4.5 in a microcentrifuge tube, placed in ice water, and irradiated with the focused beam for 5 min.
Quantitative removal of NVOC protecting groups was observed under these conditions. After photodeprotection the charged tRNA was supplied immediately to an in vitro protein synthesis reaction.
In vitro protein synthesis using S30 extract
The S30 extract was prepared from E. coli strain D10. 43 The plasmids used for this experiment encode full TFIIIA (pV-1) or encode a nonsense mutant with a TAG stop codon at amino acid position 199 (pV-199). Transcription/translation extract was mixed with 1.0 µg of plasmid DNA and 10 µg of photodeprotected aminoacylated tRNA and incubated at 37°C on a rotating wheel for 1.5 h. The protein synthesis reaction was stopped by the addition of 45 µL of acetone. After 15 min on ice, the precipitated protein products were pelleted by centrifugation. The pellet was solubilized in SDS loading dye and loaded on a 10% SDS-PAGE polyacrylamide gel and resolved by electrophoresis. The gel was blotted to a nitrocellulose membrane overnight and analyzed by western blotting using an antibody against TFIIIA. 
